2016/4 GaBI Journal Table of Contents

Contents

Editor’s Letter

Fourth and final issue of GaBI Journal’s fifth volume

Editorial

Physicians, Hippocrates and biosimilars: applying ancient principles in a modern society

Original Research

Naming and labelling of biologicals – the perspective of hospital and retail pharmacists

Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future

Review Article

Cost-minimization analysis of generic equivalents (bortezomib, decitabine and capecitabine) in comparison to the originator brand medicines in Colombia

Regulatory

Regulatory Science Ireland: bridging the information gap on biosimilar medicines

Opinion

Where does the value of ‘value-added’ pharmaceuticals come from?

Special Report

The role of European Pharmacopoeia monographs in setting quality standards for biotherapeutic products

Generic medicines entry into the Malaysian pharmaceutical market

Meeting Report

Data requirements to demonstrate biosimilarity in the EU

Abstracted Scientific Content

Effect of naming on pharmacists’ perceptions and dispensing of biosimilars

Essential information for internists on biologicals and biosimilars

An empirical study of market-based purchasing policies for generic pharmaceuticals in Sweden

Strategies used to delay or prevent access to affordable generic drugs in the US

Source URL: https://gabi-journal.net/20164-gabi-journal-table-of-contents.html